Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients.
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 58 (4), 621-631
- https://doi.org/10.2165/00003495-199958040-00004
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- CT-guided percutaneous treatment of inoperable pulmonary aspergillomas: a study of 40 casesEuropean Journal of Radiology, 1998
- Surgery for pulmonary aspergillosisEuropean Journal of Cardio-Thoracic Surgery, 1997
- Relapsing Aspergillus Bronchitis in a Double Lung Transplant Patient, Successfully Treated With a New Oral Antimycotic AgentChest, 1997
- Lipid Formulations of Amphotericin B: Recent Progress and Future DirectionsClinical Infectious Diseases, 1996
- The Safety and Efficacy of Amphotericin B Colloidal Dispersion in the Treatment of Invasive MycosesClinical Infectious Diseases, 1995
- Clinical use of liposomal and lipid-complexed amphotericin BJournal of Antimicrobial Chemotherapy, 1994
- Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single‐centre experience of 133 episodes in 116 patientsBritish Journal of Haematology, 1994
- Relationship of pharmacokinetics and drug distribution in tissue to increased safety of amphotericin B colloidal dispersion in dogsAntimicrobial Agents and Chemotherapy, 1992
- Efficacy of amphotericin B encapsulated in liposomes (AmBisome) in the treatment of invasive fungal infections in immunocompromised patientsJournal of Antimicrobial Chemotherapy, 1991
- Cure of Aspergillus ustus endocarditis on a prosthetic valve.1974